Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
The Journal of Allergy and Clinical Immunology | Oct 24, 2020
Clinical characteristics and safety of plasma-derived C1-inhibitor therapy in children and adolescents with hereditary angioedema—a long-term survey
The Journal of Allergy and Clinical Immunology: In Practice | Apr 09, 2020
Endocan: A novel marker of endothelial dysfunction in C1-inhibitor-deficient hereditary angioedema
International Archives of Allergy and Immunology | Nov 06, 2017
Endocan: A novel marker of endothelial dysfunction in C1-inhibitor-deficient hereditary angioedema
International Archives of Allergy and Immunology | Oct 31, 2017